Important Information
This Summary of Safety and Clinical Performance (SSCP) is intended
to provide public access to an updated summary of the main aspects
of the safety and clinical performance of the device. The
information presented below is intended for patients or lay
persons. A more extensive summary of safety and clinical
performance prepared for healthcare professionals is found in the
first part of this document.
The SSCP is not intended to give general advice on the treatment
of a medical condition. Please contact your healthcare
professional in case you have questions about your medical
condition or about the use of the device in your situation. This
SSCP is not intended to replace an Implant Card or the
Instructions for Use to provide information on the safe use of the
device.
1. Device Identification and General Information
Device Trade Name(s): T-3® CT Catheter
Manufacturer Name and Address: Medical
Components, Inc. 1499 Delp Drive Harleysville, PA 19438 USA
Basic UDI-DI: 00884908300MQ
Date First CE Certificate Was Issued for This Device:
11-Aug
Device Grouping and Variants
This document talks about hemodialysis tubes [catheter] sets.
These tubes are used for a short time and come in different sets.
These devices are distributed as procedure trays. Procedure trays
come in different configurations.
Variant Devices:
Variant Devices:
| Variant Description |
Part Number(s) |
| 15.5F x 15cm Straight T-3 CT |
10468-815-001 |
| 15.5F x 20cm Straight T-3 CT |
10468-820-001 |
| 15.5F x 24cm Straight T-3 CT |
10468-824-001 |
| 15.5F x 28cm Straight T-3 CT |
10468-828-001 |
| 15.5F x 32cm Straight T-3 CT |
10468-832-001 |
Variant Devices:
| Variant Description |
Part Number(s) |
| 15.5F x 15cm Straight T-3 CT |
10468-815-001 |
| 15.5F x 20cm Straight T-3 CT |
10468-820-001 |
| 15.5F x 24cm Straight T-3 CT |
10468-824-001 |
| 15.5F x 28cm Straight T-3 CT |
10468-828-001 |
| 15.5F x 32cm Straight T-3 CT |
10468-832-001 |
Procedure Trays:
Procedure Trays:
| Catalog Code |
Part Number |
Description |
| MC013501 |
10468-815-001 |
15.5F X 15cm T-3 CT Power Injectable Triple Lumen
Hemodialysis Catheter Basic Set
|
| MC013502 |
10468-820-001 |
15.5F X 20cm T-3 CT Power Injectable Triple Lumen
Hemodialysis Catheter Basic Set
|
| MC013503 |
10468-824-001 |
15.5F X 24cm T-3 CT Power Injectable Triple Lumen
Hemodialysis Catheter Basic Set
|
| MC013504 |
10468-828-001 |
15.5F X 28cm T-3 CT Power Injectable Triple Lumen
Hemodialysis Catheter Basic Set
|
| MC013505 |
10468-832-001 |
15.5F X 32cm T-3 CT Power Injectable Triple Lumen
Hemodialysis Catheter Basic Set
|
Procedure Trays:
| Catalog Code |
Part Number |
Description |
| MC013501 |
10468-815-001 |
15.5F X 15cm T-3 CT Power Injectable Triple Lumen
Hemodialysis Catheter Basic Set
|
| MC013502 |
10468-820-001 |
15.5F X 20cm T-3 CT Power Injectable Triple Lumen
Hemodialysis Catheter Basic Set
|
| MC013503 |
10468-824-001 |
15.5F X 24cm T-3 CT Power Injectable Triple Lumen
Hemodialysis Catheter Basic Set
|
| MC013504 |
10468-828-001 |
15.5F X 28cm T-3 CT Power Injectable Triple Lumen
Hemodialysis Catheter Basic Set
|
| MC013505 |
10468-832-001 |
15.5F X 32cm T-3 CT Power Injectable Triple Lumen
Hemodialysis Catheter Basic Set
|
Configurations of Procedure Trays:
| Configuration Type |
| T-3® CT Basic Set: |
2. Intended Use of the Device
Intended Purpose: T-3® CT Catheters are intended
for use in adult patients with Acute Kidney Injury (AKI) or
Chronic Kidney Disease (CKD) for whom immediate central venous
vascular access for short-term hemodialysis, intravenous
administration of fluids or medications, and power injection of
contrast media is deemed necessary based on the direction of a
qualified, licensed physician. The catheter is intended to be used
under the regular review and assessment of qualified health
professionals. This catheter is for Single Use Only.
Indication(s): The T-3® CT Catheter is indicated
for short-term use where vascular access is required for less than
14 days for the purpose of hemodialysis. The third internal lumen
is indicated for intravenous administration of fluids or
medications and power injection of contrast media.
Intended Patient Group(s): T-3® CT Catheters are
intended for use in adult patients with Acute Kidney Injury (AKI)
or Chronic Kidney Disease (CKD) for whom immediate central venous
vascular access for short-term hemodialysis, intravenous
administration of fluids or medications, and power injection of
contrast media is deemed necessary based on the direction of a
qualified, licensed physician. The catheter is not intended for
use in pediatric patients.
Contraindications and/or Limitations:
-
Known or suspected allergies to any of the components of the
catheter or the kit.
-
This device is contraindicated for patients exhibiting severe,
uncontrolled coagulopathy or thrombocytopenia.
3. Device Description
Device Name: T-3® CT Catheter
Description of Device: The T-3® Catheter is a
special tube that doctors use for cleaning blood in some people
who are sick. It's made of a special material that can change
shape when it's heated up. The tube has three different parts
inside it, which let blood flow through it continuously. There are
two parts, one that carries blue blood and one that carries red
blood, that the doctor can use to clean the blood. The middle
part, which is purple, is separate from the other two and can be
used to give patients medicine or other fluids. The tube comes in
different sizes to make sure it works well for each patient.
Device Name: T-3® CT Catheter
Description of Device: The T-3® Catheter is a
special tube that doctors use for cleaning blood in some people
who are sick. It's made of a special material that can change
shape when it's heated up. The tube has three different parts
inside it, which let blood flow through it continuously. There are
two parts, one that carries blue blood and one that carries red
blood, that the doctor can use to clean the blood. The middle
part, which is purple, is separate from the other two and can be
used to give patients medicine or other fluids. The tube comes in
different sizes to make sure it works well for each patient.
Materials / Substances in Contact with Patient Tissue:
The percentage ranges below are based on catheter weights. The
15cm catheter weighs 15.15 grams. The 32cm catheter weighs 17.91
grams.
T-3® CT Catheter
| Material |
% Weight (w/w) |
| Polyurethane |
64.09 - 66.55 |
| Acetal co-polymer |
16.46 - 19.46 |
| Acrylonitrile Butadiene Styrene |
5.57 - 6.59 |
| Silicone |
5.57 - 6.59 |
| Barium sulfate |
3.28 - 5.86 |
The percentage ranges below are based on catheter weights. The
15cm catheter weighs 15.15 grams. The 32cm catheter weighs 17.91
grams.
T-3® CT Catheter
| Material |
% Weight (w/w) |
| Polyurethane |
64.09 - 66.55 |
| Acetal co-polymer |
16.46 - 19.46 |
| Acrylonitrile Butadiene Styrene |
5.57 - 6.59 |
| Silicone |
5.57 - 6.59 |
| Barium sulfate |
3.28 - 5.86 |
Note:The device should not be used if you are allergic to the
above materials.
Information on Medicinal Substances in the Device:
How the Device Achieves its Intended Mode of Action:
Hemodialysis tubes provide access through the vein or artery. The
tube is thin and flexible and goes into a big vein near the center
of the body. There are two openings in the tube. One opening takes
out the blood and sends it to a machine that cleans it. The other
opening puts the clean blood back into the body. This tube is used
when someone needs to have their blood cleaned right away, and
they can't use a different kind of tube. This tube is only used
for a short time.
Cleaning (Sterilization) Information: Contents
are clean and will not cause fever in unopened, undamaged package.
Sterilized by Ethylene Oxide.
Accessories Intended for Use in Combination with the
Device:
| Name of Accessory |
Description of Accessory |
| Guidewire |
Acts as a path for other components. |
| Guidewire Advancer |
Helps guidewire introduction. |
| Introducer Needle |
Placed into the target vein to gain access.
|
| Dilator |
Used to make the opening of a vessel larger.
|
| Valved Peelable Introducer |
Used to get central venous access. |
| Scalpel |
A cutting device. |
| Suture |
Helps secure tube to body. |
| End Cap |
To keep the catheter clean between treatments.
|
| Syringe |
Helps get blood return once the needle punctures the vein.
|
| Adhesive Wound Dressing |
Protects tube from germs. |
4. Risks and Warnings
If you think something is wrong with how you feel after using the
device or you're worried about any problems, talk to your
healthcare professional. Remember, this information is not meant
to take the place of talking to your doctor if you need to.
How Potential Risks Have Been Controlled or Managed
There have been 9,942 devices sold since January 2019. There are
side effects and risks that you should be aware of with the
device. These include:
Infection
Bleeding
Tube Removal
Tube Replacement These risks are reduced to an acceptable level.
The labeling describes the risks. The benefit of the device is
access for hemodialysis when alternatives are not suitable. These
benefits outweigh the risks.
Remaining Risks and Undesirable Effects
The T-3® CT catheter is associated with risks. These include:
Procedural Delays
Blood clots in veins (Thrombosis)
Infections
Punctures in organs (Perforations)
Air bubbles in veins (Embolism)
Heart problems (Cardiac Event)
Feeling unhappy with the procedure (Dissatisfaction) The risks of
using the Medcomp device are similar to other dialysis tubes. The
most common problem is getting an infection. Infections can happen
when someone has surgery or stays in the hospital. Infections are
not always caused by use of the device.
|
Quantification of Residual Risks
|
|
PMS Complaints 01 January 2018 – 31 December 2023
|
PMCF Events |
|
Units Sold: 21,463 |
Units Studied: 81 |
|
Patient Residual Harm Category
|
# of Cases Per Event |
# of Cases Per Event |
| Allergic Reaction |
Not Reported. |
Not Reported. |
| Bleeding |
Not Reported. |
Not Reported. |
| Cardiac Event |
Not Reported. |
Not Reported. |
| Embolism |
Not Reported. |
Not Reported. |
| Infection |
Not Reported. |
1 Event in 80 Cases. |
| Perforation |
Not Reported. |
Not Reported. |
| Stenosis |
Not Reported. |
Not Reported. |
| Tissue Injury |
Not Reported. |
Not Reported. |
| Thrombosis |
Not Reported. |
1 Event in 40 Cases. |
Warnings and Precautions
The below are warnings, precautions, or measures to be taken by
patient:
To lower the risk of bacteria entering the catheter, wear a mask
over your nose and mouth every time the catheter is accessed.
Keep the catheter dressing clean and dry. The dressing should be
changed by a medical professional at each dialysis session.
Avoid getting the catheter or catheter site wet. Moisture near the
catheter site can cause infection.
Ask the doctor to explain the signs and symptoms of catheter
infection.
Never remove the cap at the end of the catheter. The cap and
clamps of the catheter must be kept closed when not being used for
dialysis.
Summary of Any Field Safety Correction Action (FSCA)
There were no recalls for the device between 01 January 2019 to 31
December 2023.
5. Summary of Clinical Evaluation and Post-Market Clinical
Follow-Up
Clinical Background of Device
The T-3® CT catheter has been around since 2011. The device got
approved for use in Europe in August 2011. It was also approved
for use by the US FDA in June 2013. All models included are up for
distribution in the European Union.
Clinical Evidence for CE-Marking
The clinical literature review identified two articles relating to
the safety and/or performance of the subject device when used as
intended. These articles included approximately 11 cases. Two PMCF
data activities received information on 81 catheters. Nineteen
user surveys have been received relating to this device. Studies
and tests on the T-3® CT catheter show that it can be used safely.
The advantages of using this item outweigh the dangers when it is
used as intended. This device helps people who have kidney
problems get hemodialysis when other treatments are not right for
them.
Safety
There is sufficient data to prove conformity to the applicable
requirements. The device is safe and performs as intended and
claimed by Medcomp. The device is state of the art for allowing
short-term vascular access for hemodialysis in adult patients.
Medcomp has reviewed:
Post-Market Data
Medcomp Information Materials
Risk Management Documentation The risks are appropriately
displayed and consistent with the state of the art. The risks
associated with the device product family are acceptable when
weighed against the benefits. There was 1 complaint for 9,842
units sold from 01 January 2019 to 31 December 2023. The complaint
rate is 0.01%.
6. Possible Therapeutic Alternatives
When considering alternative treatments, it is recommended to
contact your healthcare professional who can consider your
individual situation. The Kidney Disease Outcomes Quality
Initiative (KDOQI) 2019 clinical practice guidelines have been
used to support the below recommendations for treatments.
| Therapy |
Benefits |
Disadvantages |
Key Risks |
| • AV Fistula |
- Permanent solution.
-
Lower complication rate than catheter.
|
- Requires time.
-
Patients must sometimes self-needle stick.
|
- Narrowing of a vein (Stenosis)
- Thrombosis
-
Bulge in a blood vessel (Aneurysm)
-
High blood pressure in the lungs (Pulmonary
hypertension)
-
Lack of blood flow to an area (Steal Syndrome)
- Blood infection (Septicemia)
|
| • Hemodialysis Catheter |
- Useful for quick access.
-
Can be used as a bridge between therapies.
|
- Not permanent.
- Catheter dysfunction can happen.
-
Benefit may not be the same for everyone.
|
- Post-procedural bleeding
- Infection
- Thrombosis
-
Decreased blood flow in dysfunctional catheter
- Cardiovascular events
-
Fibrin sheath formation around catheter
- Septicemia
|
| • Peritoneal Dialysis |
-
Less restrictive diet than hemodialysis.
- Does not require hospitalization.
|
-
Clearance of impurities is limited by flow and space.
|
-
Infection of the abdomen (Peritonitis)
- Septicemia
- Fluid overload
|
| • Kidney Transplant |
- Better quality of life.
- Lower risk of death.
- Fewer food restrictions.
|
- Requires a donor.
- More risky for certain groups.
-
Patient must take medication for life.
- Medication has side effects.
|
- Thrombosis
- Severe bleeding (Hemorrhage)
-
Blockage of the tubes that carry urine (Ureteral
blockage)
- Infection
- Organ rejection
- Death
-
Heart problem (Myocardial infarction)
-
Blocked blood flow to brain (Stroke)
|
| • Comprehensive Conservative Care |
- Less imposed symptom burden.
- Preserves life satisfaction.
|
- May aggravate clinical condition.
- Not designed to treat.
|
-
Treatment may not actually minimize risks associated
with CKD.
|
7. Suggested Profile and Training for Users
The catheter should be inserted, manipulated, and removed by a
qualified, licensed physician or other qualified health care
professional under the direction of a physician.
Acronyms
| Abbreviation |
Definition |
| AKI |
Acute Kidney Injury |
| AV |
Arteriovenous |
| CE |
Conformité Européenne (European Conformity)
|
| CKD |
Chronic Kidney Disease |
| cm |
centimeter |
| CMR |
Carcinogenic, mutagenic, reprotoxic |
| CVC |
Central Venous Catheter |
| EU |
European Union |
| F |
French (thickness of catheter) |
| FDA |
Food and Drug Administration |
| FSCA |
Field Safety Corrective Action |
| HD |
Hemodialysis |
| KDOQI |
Kidney Disease Outcomes Quality Initiative
|
| PA |
Pennsylvania |
| PMCF |
Post Market clinical follow-up |
| PMS |
Post Market Surveillance |
| SSCP |
Summary of Safety and Clinical Performance
|
| STHD |
Short-term Hemodialysis |
| USA |
United States of America |
| w/w |
Weight over Weight |